Abstract:Reactive oxygen species (ROS) generated by NADPH oxidase play an important role in antimicrobial host defense and inflammation. Their deficiency in humans results in recurrent and severe bacterial infections, while their unregulated release leads to pathology from excessive inflammation. The release of high concentrations of ROS aids in clearance of invading bacteria. Localization of ROS release to phagosomes containing pathogens limits tissue damage. Host immune cells, like neutrophils, also known as PMNs, will release large amounts of ROS at the site of infection following the activation of surface receptors. The binding of ligands to G-protein-coupled receptors (GPCRs), toll-like receptors, and cytokine receptors can prime PMNs for a more robust response if additional signals are encountered. Meanwhile, activation of Fc and integrin directly induces high levels of ROS production. Additionally, GPCRs that bind to the bacterial-peptide analog fMLP, a neutrophil chemoattractant, can both prime cells and trigger low levels of ROS production. Engagement of these receptors initiates intracellular signaling pathways, resulting in activation of downstream effector proteins, assembly of the NADPH oxidase complex, and ultimately, the production of ROS by this complex. Within PMNs, ROS released by the NADPH oxidase complex can activate granular proteases and induce the formation of neutrophil extracellular traps (NETs). Additionally, ROS can cross the membranes of bacterial pathogens and damage their nucleic acids, proteins, and cell membranes. Consequently, in order to establish infections, bacterial pathogens employ various strategies to prevent restriction by PMN-derived ROS or downstream consequences of ROS production. Some pathogens are able to directly prevent the oxidative burst of phagocytes using secreted effector proteins or toxins that interfere with translocation of the NADPH oxidase complex or signaling pathways needed for its activation. Nonetheless, these pathogens often rely on repair and detoxifying proteins in addition to these secreted effectors and toxins in order to resist mammalian sources of ROS. This suggests that pathogens have both intrinsic and extrinsic mechanisms to avoid restriction by PMN-derived ROS. Here, we review mechanisms of oxidative burst in PMNs in response to bacterial infections, as well as the mechanisms by which bacterial pathogens thwart restriction by ROS to survive under conditions of oxidative stress.

Reactive Oxygen Species: Do They Play a Role in Adaptive Immunity?

The Role of Reactive Oxygen Species in Regulating T Cell-mediated Immunity and Disease

Reactive Oxygen Species: the Signal Regulator of B Cell

Exercise Cuts Both Ways with ROS in Remodifying Innate and Adaptive Responses: Rewiring the Redox Mechanism of the Immune System during Exercise

ROS signaling in innate immunity via oxidative protein modifications

Functions of ROS in Macrophages and Antimicrobial Immunity

Reactive oxygen species: from health to disease

Redox regulation of the immune response

Unraveling the Role of Reactive Oxygen Species in T Lymphocyte Signaling

Innate-adaptive immunity interplay and redox regulation in immune response

Reactive Oxygen Species: Beyond Their Reactive Behavior

The Protective Role of ROS in Autoimmune Disease

Mitochondrial Reactive Oxygen Species in Infection and Immunity

The Influence of Reactive Oxygen Species in the Immune System and Pathogenesis of Multiple Sclerosis

Redox Activation of Mitochondrial DAMPs and the Metabolic Consequences for Development of Autoimmunity

Reactive oxygen and nitrogen species in normal physiological processes

Reactive oxygen species formation and its effect on CD4+ T cell-mediated inflammation

ROS-associated immune response and metabolism: a mechanistic approach with implication of various diseases

ROS Fine-Tunes the Function and Fate of Immune Cells

Reactive Oxygen Species in Anticancer Immunity: A Double-Edged Sword

Neutrophils to the ROScue: Mechanisms of NADPH Oxidase Activation and Bacterial Resistance